Financials data is unavailable for this security.
View more
Year on year Nanobiotix SA grew revenues -- from 0.00 to 30.06m while net income improved from a loss of 57.04m to a smaller loss of 39.70m.
Gross margin | -- |
---|---|
Net profit margin | -132.08% |
Operating margin | -88.14% |
Return on assets | -51.67% |
---|---|
Return on equity | -- |
Return on investment | -120.56% |
More ▼
Cash flow in EURView more
In 2023, Nanobiotix SA increased its cash reserves by 81.90%, or 33.90m. Cash Flow from Financing totalled 46.77m or 155.60% of revenues. In addition the company used 12.48m for operations while cash used for investing totalled 349.00k.
Cash flow per share | -1.15 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0437 |
---|---|
Tangible book value per share | -0.0439 |
More ▼
Balance sheet in EURView more
Current ratio | 1.75 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.04 |
More ▼